|
THAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.813160E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.971000E-01 |
| Normal-vs-Stage2 |
1.139760E-01 |
| Normal-vs-Stage3 |
3.102100E-02 |
| Normal-vs-Stage4 |
1.716360E-01 |
| Stage1-vs-Stage2 |
1.866790E-01 |
| Stage1-vs-Stage3 |
3.398100E-02 |
| Stage1-vs-Stage4 |
2.683200E-01 |
| Stage2-vs-Stage3 |
8.240400E-01 |
| Stage2-vs-Stage4 |
8.546000E-01 |
| Stage3-vs-Stage4 |
6.591600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.626950E-01 |
| Normal-vs-AfricanAmerican |
7.554400E-01 |
| Normal-vs-Asian |
8.867400E-01 |
| Caucasian-vs-AfricanAmerican |
5.344200E-01 |
| Caucasian-vs-Asian |
1.264360E-01 |
| AfricanAmerican-vs-Asian |
6.450400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.886100E-02 |
| Normal-vs-Female |
3.376800E-01 |
| Male-vs-Female |
8.084100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.240800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.184000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.753500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.415180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.139600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.559800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.989180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.357960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.009400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.265600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.406430E-01 |
| Classical-VS-Follicular |
1.585680E-02 |
| Classical-VS-Other |
8.170800E-01 |
| Classical-VS-Normal |
5.465400E-01 |
| Tall-VS-Follicular |
9.222800E-01 |
| Tall-VS-Other |
5.296600E-01 |
| Tall-VS-Normal |
7.848100E-02 |
| Follicular-VS-Other |
5.078000E-01 |
| Follicular-VS-Normal |
3.476300E-02 |
| Other-VS-Normal |
9.297600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.402100E-02 |
| Normal-vs-N1 |
2.613400E-01 |
| N0-vs-N1 |
8.544600E-01 |
|
|
